Clinical Trials Directory

Trials / Unknown

UnknownNCT05270122

ThrombX Retriever for Acute Ischemic Stroke Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
ThrombX Medical · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This trial is designed to assess the safety and effectiveness of the ThrombX Retriever.

Detailed description

This trial is a clinical evaluation is to assess the safety and effectiveness of the ThrombX Retriever in the revascularization of the site of primary occlusion in patients presenting with acute ischemic stroke secondary to intracranial, large vessel, occlusive disease.

Conditions

Interventions

TypeNameDescription
DEVICEMechanical thrombectomy with ThrombX RetrieverRevascularization

Timeline

Start date
2022-05-01
Primary completion
2024-04-01
Completion
2024-07-01
First posted
2022-03-08
Last updated
2022-03-28

Regulatory

Source: ClinicalTrials.gov record NCT05270122. Inclusion in this directory is not an endorsement.

ThrombX Retriever for Acute Ischemic Stroke Trial (NCT05270122) · Clinical Trials Directory